Brett Swansiger

Brett Swansiger has over 22 years of commercial leadership, international business development, and managed care contracting experience within the molecular diagnostics and pharmaceutical industries.

Prior to joining DxTerity, Brett held multiple commercial leadership positions at MDxHealth Inc., a multi-national urologic oncology company, including SVP of Managed Care and Payer Strategy, SVP International Business Development & European Sales, and SVP of US Sales & Integrated Healthcare Systems. Brett was successful in executing licensing and clinical study contracts with diagnostic and pharmaceutical market leaders as well as getting key integrated healthcare systems like Kaiser Permanente, the Veteran’s Administration, the Department of Defense, and Geisinger to adopt new molecular diagnostic testing clinical pathways.

Prior to joining MDxHealth, Brett was Vice President of Managed Care and Asia Market Access for Agendia Inc., and he held multiple commercial leadership positions at Prometheus Laboratories Inc., a Nestlé Health Science company that focuses on personalized medicine for autoimmune disorders.